换一批Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.
第一作者：
Anna,Morra
第一单位：
Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
作者：
Anna,Morra [1]
;
Maartje A C,Schreurs [2]
;
Irene L,Andrulis [3]
;
Hoda,Anton-Culver [4]
;
Annelie,Augustinsson [5]
;
Matthias W,Beckmann [6]
;
Sabine,Behrens [7]
;
Stig E,Bojesen [8]
;
Manjeet K,Bolla [9]
;
Hiltrud,Brauch [10]
;
Annegien,Broeks [1]
;
Saundra S,Buys [11]
;
Nicola J,Camp [11]
;
Jose E,Castelao [12]
;
Melissa H,Cessna [13]
;
Jenny,Chang-Claude [14]
;
Wendy K,Chung [15]
;
NBCS Collaborators [16]
;
Sarah V,Colonna [11]
;
Fergus J,Couch [17]
;
Angela,Cox [18]
;
Simon S,Cross [19]
;
Kamila,Czene [20]
;
Mary B,Daly [21]
;
Joe,Dennis [9]
;
Peter,Devilee [22]
;
Thilo,Dörk [23]
;
Alison M,Dunning [24]
;
Miriam,Dwek [25]
;
Douglas F,Easton [26]
;
Diana M,Eccles [27]
;
Mikael,Eriksson [20]
;
D Gareth,Evans [28]
;
Peter A,Fasching [6]
;
Tanja N,Fehm [29]
;
Jonine D,Figueroa [30]
;
Henrik,Flyger [31]
;
Marike,Gabrielson [20]
;
Manuela,Gago-Dominguez [32]
;
Montserrat,García-Closas [33]
;
José A,García-Sáenz [34]
;
Jeanine,Genkinger [35]
;
Felix,Grassmann [36]
;
Melanie,Gündert [37]
;
Eric,Hahnen [38]
;
Christopher A,Haiman [39]
;
Ute,Hamann [40]
;
Patricia A,Harrington [24]
;
Jaana M,Hartikainen [41]
;
Reiner,Hoppe [42]
;
John L,Hopper [43]
;
Richard S,Houlston [44]
;
Anthony,Howell [45]
;
ABCTB Investigators [46]
;
kConFab Investigators [47]
;
Anna,Jakubowska [48]
;
Wolfgang,Janni [49]
;
Helena,Jernström [5]
;
Esther M,John [50]
;
Nichola,Johnson [51]
;
Michael E,Jones [44]
;
Vessela N,Kristensen [52]
;
Allison W,Kurian [50]
;
Diether,Lambrechts [53]
;
Loic,Le Marchand [54]
;
Annika,Lindblom [55]
;
Jan,Lubiński [56]
;
Michael P,Lux [6]
;
Arto,Mannermaa [57]
;
Dimitrios,Mavroudis [58]
;
Anna Marie,Mulligan [59]
;
Taru A,Muranen [60]
;
Heli,Nevanlinna [60]
;
Ines,Nevelsteen [61]
;
Patrick,Neven [61]
;
William G,Newman [28]
;
Nadia,Obi [62]
;
Kenneth,Offit [63]
;
Andrew F,Olshan [64]
;
Tjoung-Won,Park-Simon [23]
;
Alpa V,Patel [65]
;
Paolo,Peterlongo [66]
;
Kelly-Anne,Phillips [67]
;
Dijana,Plaseska-Karanfilska [68]
;
Eric C,Polley [69]
;
Nadege,Presneau [25]
;
Katri,Pylkäs [70]
;
Brigitte,Rack [49]
;
Paolo,Radice [71]
;
Muhammad U,Rashid [72]
;
Valerie,Rhenius [24]
;
Mark,Robson [73]
;
Atocha,Romero [74]
;
Emmanouil,Saloustros [75]
;
Elinor J,Sawyer [76]
;
Rita K,Schmutzler [77]
;
Sabine,Schuetze [49]
;
Christopher,Scott [69]
;
Mitul,Shah [24]
;
Snezhana,Smichkoska [78]
;
Melissa C,Southey [79]
;
William J,Tapper [27]
;
Lauren R,Teras [65]
;
Rob A E M,Tollenaar [80]
;
Katarzyna,Tomczyk [51]
;
Ian,Tomlinson [81]
;
Melissa A,Troester [64]
;
Celine M,Vachon [82]
;
Elke M,van Veen [28]
;
Qin,Wang [9]
;
Camilla,Wendt [83]
;
Hans,Wildiers [61]
;
Robert,Winqvist [70]
;
Argyrios,Ziogas [4]
;
Per,Hall [84]
;
Paul D P,Pharoah [26]
;
Muriel A,Adank [85]
;
Antoinette,Hollestelle [2]
;
Marjanka K,Schmidt [86]
;
Maartje J,Hooning [2]
作者单位：
Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
[1]
Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
[2]
Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.;Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
[3]
Department of Medicine, Genetic Epidemiology Research Institute, University of California Irvine, Irvine, California, USA.
[4]
Oncology, Clinical Sciences in Lund, Lund University, Lund, Sweden.
[5]
Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany.
[6]
Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
[7]
Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.;Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.;Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
[8]
Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
[9]
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.;iFIT-Cluster of Excellence, University of Tübingen, Tübingen, Germany.;German Cancer Consortium (DKTK), Partner Site Tübingen, German Cancer Research Center (DKFZ), Tübingen, Germany.
[10]
Department of Internal Medicine and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
[11]
Oncology and Genetics Unit, Instituto de Investigación Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, Vigo, Spain.
[12]
Intermountain Healthcare, Salt Lake City, Utah, USA.
[13]
Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.;Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
[14]
Departments of Pediatrics and Medicine, Columbia University, New York, New York, USA.
[15]
Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Oslo, Norway.;Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.;Department of Research, Vestre Viken Hospital, Drammen, Norway.;Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.;Division of Surgery, Cancer and Transplantation Medicine, Department of Oncology, Oslo University Hospital-Radiumhospitalet, Oslo, Norway.;Department of Oncology, Akershus University Hospital, Lørenskog, Norway.;Oslo Breast Cancer Research Consortium, Oslo University Hospital, Oslo, Norway.;Department of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.;Department of Community Medicine, The Arctic University of Norway, Tromsø, Norway.;Core Facility for Biobanking, The Arctic University of Norway, Tromsø, Norway.
[16]
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
[17]
Department of Oncology and Metabolism, Sheffield Institute for Nucleic Acids (SInFoNiA), University of Sheffield, Sheffield, UK.
[18]
Department of Neuroscience, Academic Unit of Pathology, University of Sheffield, Sheffield, UK.
[19]
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
[20]
Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
[21]
Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.;Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.
[22]
Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
[23]
Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
[24]
School of Life Sciences, University of Westminster, London, UK.
[25]
Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.;Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
[26]
Faculty of Medicine, University of Southampton, Southampton, UK.
[27]
Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.;North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
[28]
Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
[29]
Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.;Cancer Research UK Edinburgh Centre, The University of Edinburgh, Edinburgh, UK.;Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
[30]
Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
[31]
Cancer Genetics and Epidemiology Group, SERGAS, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS) Foundation, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
[32]
Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
[33]
Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
[34]
Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA.;Herbert Irving Comprehensive Cancer Center, New York, New York, USA.
[35]
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.;Health and Medical University, Potsdam, Germany.
[36]
Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg, Germany.;Molecular Biology of Breast Cancer, University Womens Clinic Heidelberg, University of Heidelberg, Heidelberg, Germany.;Institute of Diabetes Research, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
[37]
Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.;Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
[38]
Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
[39]
Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
[40]
Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.;Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.
[41]
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.;University of Tübingen, Tübingen, Germany.
[42]
Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
[43]
Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
[44]
Division of Cancer Sciences, University of Manchester, Manchester, UK.
[45]
Australian Breast Cancer Tissue Bank, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.
[46]
Research Department, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.;Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
[47]
Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.;Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland.
[48]
Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
[49]
Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California, USA.;Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA.
[50]
The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
[51]
Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.;Department of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.
[52]
Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.;VIB Center for Cancer Biology, VIB, Leuven, Belgium.
[53]
Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.
[54]
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.;Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
[55]
Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
[56]
Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.;Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.;Biobank of Eastern Finland, Kuopio University Hospital, Kuopio, Finland.
[57]
Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece.
[58]
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.;Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.
[59]
Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
[60]
Department of Oncology, Leuven Multidisciplinary Breast Center, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.
[61]
Institute for Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
[62]
Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.;Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
[63]
Department of Epidemiology, Gillings School of Global Public Health and UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
[64]
Department of Population Science, American Cancer Society, Atlanta, Georgia, USA.
[65]
IFOM ETS - The AIRC Institute of Molecular Oncology, Genome Diagnostics Program, Milan, Italy.
[66]
Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.;Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.;Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
[67]
Research Centre for Genetic Engineering and Biotechnology 'Georgi D. Efremov', MASA, Skopje, Republic of North Macedonia.
[68]
Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
[69]
Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland.;Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre Oulu, Oulu, Finland.
[70]
Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, "Predictive Medicine: Molecular Bases of Genetic Risk", Milan, Italy.
[71]
Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.;Department of Basic Sciences, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Lahore, Pakistan.
[72]
Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
[73]
Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain.
[74]
Department of Oncology, University Hospital of Larissa, Larissa, Greece.
[75]
School of Cancer & Pharmaceutical Sciences, Comprehensive Cancer Centre, Guy's Campus, King's College London, London, UK.
[76]
Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.;Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.;Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
[77]
Medical Faculty, University Clinic of Radiotherapy and Oncology, Ss. Cyril and Methodius University in Skopje, Skopje, Republic of North Macedonia.
[78]
Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.;Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, Australia.;Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
[79]
Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
[80]
Cancer Research Centre, The University of Edinburgh, Edinburgh, UK.
[81]
Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
[82]
Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.;Department of Oncology, Södersjukhuset, Stockholm, Sweden.
[83]
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.;Department of Oncology, Södersjukhuset, Stockholm, Sweden.
[84]
Family Cancer Clinic, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
[85]
Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.;Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
[86]
医学主题词
女(雌)性(Female);人类(Humans);乳腺肿瘤(Breast Neoplasms);疾病遗传易感性(Genetic Predisposition to Disease);生殖细胞系突变(Germ-Line Mutation);杂合子(Heterozygote);比例危险度模型(Proportional Hazards Models)
DOI
10.1002/cam4.6272
PMID
37401034
发布时间
2025-07-07
- 浏览1
Cancer medicine
Cancer medicine
2023年12卷15期
16142-16162页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
